Previous 10 | Next 10 |
2023-03-08 11:36:51 ET Summary Ongoing losses are likely to continue weighing on the stock, particularly as the Portland site starts up and begins to drag on gross profit margins. 2024 is potentially setting up to be a more positive year for Twist, with the launch of their data st...
Summary 23andMe has made many strategic acquisitions that have helped the company expand and grow. The genomics industry as a whole is expected to have rapid growth in the future due to the convenience of testing kits as well as the decreased prices. ME stock has invested a lot into...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Since the biotech bonanza of the pandemic era, many biotech stocks have rocketed up and then down in price. Ginkgo Bioworks (NYSE: DNA ), Twist Bioscience (NASDAQ: TWST ), and Amyris (NASDAQ: AMRS ) all fell...
SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Twist Bioscience Corporation (NASDAQ: TWST). Investors who purchased shares of Twist Bioscience Corporation long term and continue to hold any ...
Demonstrates Ability to Generate Humanized PSMA-Specific VHH Single Domain Antibodies via Single B Cell Screening on the Beacon Platform Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its si...
It was a rough two years for Cathie Wood, but the Ark Invest founder, CEO, and money manager is bouncing back in 2023. Her family of growth-oriented exchange-traded funds is rolling again. Wood's transparency finds Ark announcing all of its daily transactions. She added to existing positions ...
Additional sequencing applications and reference standards to be highlighted at the conference Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced technology...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 5, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is i...
Twist Bioscience Corp (TWST) Q1 2023 Earnings Conference Call February 03, 2023, 08:00 ET Company Participants Angela Bitting - Chief ESG Officer & SVP, Corporate Affairs Emily Leproust - Co-Founder, Chairman & CEO James Thorburn - CFO Conference Call Par...
Shares of Twist Bioscience (NASDAQ: TWST) were sinking 17.5% as of 11:18 a.m. ET on Friday. The steep decline came after the synthetic DNA maker announced its fiscal 2023 first-quarter results. Twist reported Q1 revenue of $54.2 million, up 29% year over year. This revenue total narro...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...